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Background: Use of antibiotics to treat humans and animals is increasing worldwide, but evidence from low-
and middle-income countries (LMICs) is limited. We conducted cross-sectional surveys in households and farms
in Uganda to assess patterns of antibiotic use among humans and animals.
Methods: Between May and December 2018, a convenience sample of 100 households in Nagongera (rural),
174 households in Namuwongo (urban) and 115 poultry and piggery farms in Wakiso (peri-urban) were selected
and enrolled. Using the ‘drug bag’ method, participants identified antibiotics they used frequently and the sour-
ces of these medicines. Prevalence outcomes were compared between different sites using prevalence ratios
(PRs) and chi-squared tests.
Results: Nearly all respondents in Nagongera and Namuwongo reported using antibiotics to treat household
members, most within the past month (74.7% Nagongera versus 68.8% Namuwongo, P"0.33). Use of metro-
nidazole was significantly more common in Namuwongo than in Nagongera (73.6% versus 40.0%, PR 0.54, 95%
CI: 0.42–0.70, P , 0.001), while the opposite was true for amoxicillin (33.3% versus 58.0%, PR 1.74, 95% CI:
1.33–2.28, P , 0.001).Veterinary use of antibiotics within the past month was much higher in Wakiso than
in Nagongera (71.3% versus 15.0%, P , 0.001). At both sites, oxytetracycline hydrochloride was the most fre-
quently used veterinary antibiotic, but it was used more commonly in Wakiso than in Nagongera (76.5% versus
31.0%, PR 0.41, 95% CI: 0.30–0.55, P , 0.001).
Conclusions: Antibiotics are used differently across Uganda. Further research is needed to understand why anti-
biotics are relied upon in different ways in different contexts. Efforts to optimize antibiotic use should be tailored
to specific settings.
Introduction
Increased use of antimicrobial medicines for treatment of humans
and animals is understood to be driving the development of anti-
microbial resistance (AMR) worldwide.1–3 As concerns about AMR
grow, global health actors have emphasized the need to reduce
unnecessary use of antimicrobials.4–6 The WHO Global Action Plan
on AMR highlights the importance of optimal use of antimicrobial
medicines in human and animal health, specifically aiming to re-
duce consumption of antimicrobial agents worldwide.4 However,
while evidence suggests an increasing trend in global consumption
of antimicrobials, particularly antibiotics, among both humans and
animals,7,8country-level data on antibiotic use are patchy.9
Current information on antibiotic consumption is drawn from im-
port and sales data at a national level. Low- and middle-income
countries (LMICs) are reportedly major contributors to the global
increase in antibiotic use,7,10 but evidence from LMICs is limited.11
Data are available from only 16 African countries7,10 and patterns
of antibiotic use in LMICs are not well understood.11
Evidence on hospital prescribing practices has informed
stewardship programmes aiming to reduce antibiotic use in
hospitals.12–15 However, while antibiotic use outside of hospitals is
substantial,16,17 relatively little is known about community-level
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use of antibiotics in LMICs, including the geographic distribution of
antibiotic use amongst households and farms, and the frequency
and types of antibiotics used. Without this detailed information,
interventions to optimize antibiotic use will be limited to a generic
design, which has hampered the effectiveness of rational drug-use
programmes in the past.18–20 In Uganda, the prevalence of anti-
biotic use in the community has been reported to range from 39%
to 44%, including 43% for use of antibiotics among children
,5 years of age with acute respiratory infections in the prior month
in urban Kampala,21 44% for treatment of cough with co-
trimoxazole among children ,5 years of age in the 2 weeks prior in
rural Tororo,22 39% for antibiotic use in the prior month among
hospitalized patients in urban Kampala23 and 39% for antibiotic
use among households reporting acute illness 2 weeks prior to the
survey.24 Frequent use of antibiotics in poultry farms was reported
by 97% of farmers in a study conducted in peri-urban Wakiso25
and the use of tetracycline for routine management of animal
health was reported by 66% of farmers interviewed in rural
Nakaseke.26 To better understand patterns of antibiotic use in
Uganda, we conducted cross-sectional surveys in three geographic
locations, focusing on both households and piggery and poultry




Cross-sectional surveys were conducted in the following three locations
(Figure 1). (1) Nagongera subcounty is in Tororo district in Eastern Uganda,
a rural area where most residents engage in agriculture as their main
economic activity.27 In Nagongera, we collected information on antibiotic
use for humans and any animals associated with the households. (2)
Namuwongo, in Kampala city, is a large informal settlement where many
people who work in the city centre and the surrounding affluent neighbour-
hoods reside.28 In Namuwongo, where few animals are kept, we collected
data on antibiotic use among humans only. (3) Wakiso district is a
Figure 1. Map of study areas. The study was conducted in: (1) Nagongera subcounty, Tororo district; (2) Namuwongo informal settlement, Kampala
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peri-urban area approximately 20 km north-west of Kampala and is an
agricultural district that has been ranked as a top producer of poultry and
piggery in Uganda.29 In Wakiso, we collected data on antibiotic use from
small- and large-scale poultry and piggery farmers.
Recruitment
Potential participants were identified with the help of field guides, including
local council leaders and village health team members in Nagongera and
Namuwongo, and animal health workers in Wakiso. In Nagongera and
Namuwongo, households were included if: (1) at least one adult (18 years
old) was present; (2) household members were permanent residents (lived
in the area for at least 6 months); and (3) the adult agreed to provide writ-
ten informed consent. In Wakiso, farms were included if the farm owner:
(1) was present or could be reached by phone; and (2) agreed to provide
written informed consent. Households and farms were excluded if an adult
resident or farm owner could not be located after at least two visits.
Participants were selected using convenience sampling, but we attempted
to recruit a cross-sectional sample of the population in each study site.
Survey procedures
Prior to the surveys, the study team met with local health and veterinary
officials, and village leaders, to discuss the survey plans. The survey was
conducted using the ‘drug bag’ method.30 First, we visited local drug shops,
pharmacies, private clinics and public health facilities. With the help of
Ugandan pharmacists, we compiled a list of antibiotics available for human
and animal use. Subsequently, we purchased packets, bottles, tablets, cap-
sules and vials of the antibiotics reported to be most commonly requested.
These medicines were put into drug bags, one for human antibiotics and
another for animal antibiotics. During the surveys, we presented the drug
bag to participants and asked them to ‘pile sort’ the medicines into four
different categories, including drugs they: (1) recognized; (2) had ever used;
(3) used frequently; and (4) needed, but could not get. While the partici-
pants sorted the medicines, we used a pre-set questionnaire to gather
information about their experiences using these medicines.
Data management and statistical analysis
Data were collected using hand-held tablets, which were programmed
using Open Data Kit (ODK) (accessible at www.opendatakit.org). We classi-
fied antibiotic use into two categories: (1) any antibiotic use (ever used):
defined as taking any antibiotic, for any indication, with any dosage, with or
without a prescription, as reported by participants; and (2) frequent
antibiotic use: self-reported by study participants during the pile-sorting ex-
ercise and defined during analysis as antibiotic use within the past month.
Questionnaire data were transferred daily from the tablets to a password-
protected laptop. At the end of the survey the complete databases were
stored on a secure server at the Infectious Diseases Research Collaboration
(IDRC) in Kampala. Data were analysed using Stata 14 (StataCorp LLC,
College Station, TX, USA).
Antibiotics for human use were categorized using the WHO AWaRe clas-
sification31 as: (1) Access: first- and second-choice antibiotics for common
infections that should be widely available, affordable and quality assured;
(2) Watch: first- and second-choice antibiotics recommended for a specific
and limited number of indications, given their association with AMR; and (3)
Reserve: antibiotics that should be treated as a ‘last resort’, limited to highly
specific patients and settings, and used only when all alternatives have
failed. The WHO AWaRe classification aims to inform effective antimicrobial
stewardship and ensure access to necessary antibiotics and appropriate
prescribing.31 Antibiotics used for animals were interpreted using the WHO
list of critically important antimicrobials for human medicine (WHO CIA),
which classifies antimicrobials as: (1) critically important; (2) highly import-
ant; or (3) important, based on their indications for treatment of humans.
This list aims to ensure that antimicrobials, particularly those classified as
critically important, are used with caution, both in human and veterinary
medicine.32
In the analysis, descriptive statistics were generated and proportions
were reported for each variable. Chi-squared tests were used to compare
participant characteristics between the study sites. Prevalence ratios
(PRs) were generated for comparisons between the study sites of data on
prevalence of any antibiotic use, frequent antibiotic use, different antibiotics
used and the source of antibiotics. The PR in our study was the ratio of the
outcome of interest (proportion of participants who reported any antibiotic
use, frequent antibiotic use, use of different antibiotics and source of antibi-
otics) divided by the proportion of participants surveyed, in a given geo-
graphic location.
Ethics
We obtained ethics approval for the study from the School of
Biomedical Sciences Research and Ethics Committee, Makerere
University College of Health of Sciences (SBSREC REF no. 562), the
Uganda National Council for Science and Technology (SS 4679) and the
London School of Hygiene and Tropical Medicine Ethics Committee
(LSHTM Ethics Ref: 15244).
Results
Baseline characteristics
From November to December 2018, 100 participants were enrolled
in Nagongera, and from May to June 2018, 174 and 115 partici-
pants were enrolled in Namuwongo and Wakiso, respectively
(Figure 2). The characteristics of participants enrolled in the three
sites varied (Table 1). Considering the population evaluated for
antibiotic use in humans, more respondents were female in
Namuwongo than in Nagongera (79.3% versus 56.0%, respective-
ly). In Nagongera, 89.0% of respondents were subsistence farm-
ers, while in Namuwongo, 85.1% were either merchants or
labourers (involved in making, building or fixing things, or cooking
and cleaning). Considering the population evaluated for antibiotic
use in animals, respondents in Nagongera and Wakiso were similar
in gender and age (Table 1), but education, occupation and farm
characteristics varied. In Nagongera, 16.0% of respondents had
received no education and 49.0% only reached primary school,
while in Wakiso, 78.8% of participants reached secondary school
or higher. In Nagongera, no respondents owned their farm, while
in Wakiso, 72.2% were farm owners. In Nagongera, all farms were
classified as subsistence farms with little capacity to produce sur-
plus for the market, while all farms in Wakiso were commercial,
mostly small-scale farms.
Patterns and sources of antibiotics in humans
Nearly all respondents in Nagongera and Namuwongo reported
using antibiotics to treat illness in their households (Table 2), most
within the past month (74.7% in Nagongera versus 68.8% in
Namuwongo). Far more participants in Nagongera reported
obtaining medicines from public health facilities than in
Namuwongo (84.2% versus 22.9%), but in both areas most partici-
pants reported obtaining medicines from the private sector (87.4%
in Nagongera versus 75.9% in Namuwongo). In Namuwongo, the
drug bag contained 24 antibiotics; 21 of these were recognized
by respondents and 18 were used frequently (Figure 3). In
Nagongera, the drug bag contained only 20 antibiotics; 16 of these
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were recognized by respondents and 13 were used frequently. In
both sites, the drug bag for humans did not include any antibiotics
classified as ‘reserve’ drugs because these drugs were rarely
requested. The most frequently used antibiotic in Nagongera was
amoxicillin, while in Namuwongo it was metronidazole (Table 3).
Use of amoxicillin was significantly more common in Nagongera
than in Namuwongo (58.0% versus 33.3%, PR 1.74, 95% CI:
1.33–2.28, P , 0.001), while the opposite was true for metronida-
zole (40.0% versus 73.6%, PR 0.54, 95% CI: 0.42–0.70, P , 0.001).
Ampicillin/cloxacillin and trimethoprim/sulfamethoxazole were
also frequently used, ampicillin/cloxacillin more commonly in
Namuwongo (45.4% in Namuwongo versus 14.0% in Nagongera)
and trimethoprim/sulfamethoxazole more commonly in
Nagongera (42.0% in Nagongera versus 28.7% in Namuwongo).
Ciprofloxacin and erythromycin, classified as drugs to ‘watch’ in
the WHO AWaRe system, were used more often in Namuwongo
than in Nagongera (ciprofloxacin PR 0.54, 95% CI: 0.27–1.09,
P" 0.10 and erythromycin PR 0.49, 95% CI: 0.24–0.98, P"0.04),
although this difference was significant only for erythromycin.
Patterns and sources of antibiotics in animals
Veterinary use of antibiotics was reported in both Wakiso and
Nagongera (Table 4) but was far more common in Wakiso (86.1%
versus 33.0%, respectively). Of those participants who reported
ever using antibiotics to treat animals, significantly more partici-
pants in Wakiso had used antibiotics over the past month (82.8%
in Wakiso versus 45.5% in Nagongera, PR 0.55, 95% CI: 0.37–0.81,
P , 0.001). In both areas, medicines were obtained frequently
from the private sector. In Wakiso, the antibiotic bag contained 21
antibiotics; all of these were recognized by respondents and 20
were used frequently (Figure 4). In Nagongera, the drug bag con-
tained only 16 antibiotics; 10 of these were recognized by respond-
ents and 7 were used frequently. In both sites, all 15 of the
antibiotics classified as ‘critically important’ that were included in
the drug bags were recognized by participants in Wakiso, while
only 7 were recognized in Nagongera. In both sites, the most fre-
quently used antibiotic was oxytetracycline hydrochloride
(Table 5), which was used more often in Wakiso than in Nagongera
(76.5% versus 31.0%, respectively, PR 0.41, 95% CI: 0.30–0.55,
P , 0.001). In Wakiso, three other commonly used antibiotics
(dihydrostreptomycin sulphate, erythromycin sulphate and tylosin
tartrate) are classified as ‘critically important’ in the WHO CIA sys-
tem; all three were used more often in Wakiso than in Nagongera
(Figure 4, Table 5), although this difference was not significant for
erythromycin sulphate. Of note, use of colistin, another ‘critically
important’ antimicrobial, was reported by some respondents in
Wakiso, either alone or in combination with other antibiotics.
Discussion
Current efforts to optimize antibiotic use outside of hospitals rely
on key messages to increase awareness of AMR and discourage
the misuse of antibiotics. However, lack of data to inform these
messages, and the generic nature of centralized global messaging,
limit their impact on antibiotic use.33,34 Our findings provide im-
portant insights into the current status of antibiotic use in Uganda.
Here, the stark difference in patterns of antibiotic use in three dif-
ferent settings—rural, urban and peri-urban—suggests that inter-
ventions will need to be tailored to specific sites and populations.
Overall, the frequency of antibiotic use amongst residents and
farmers was high, underscoring a trend signalled in estimates of
global use of antibiotics for human treatment, derived from im-
port/sales data,7,10 as well as the projected trajectory of antibiotic
use in animals based on increasing livestock farming.35 High levels
of antibiotic use have been reported amongst residents in rural
Nigeria where 82% of respondents had used an antibiotic in the
past 6 months,36 and in an informal settlement in urban Kenya
where 87% reported using antibiotics in the last 12 months.37
However, other research studies, conducted in Uganda and else-
where in Africa between 2007 and 2017, have reported lower
prevalence of antibiotic use; in a household survey conducted in
415 individuals screened 
Namuwongo 
 
190 individuals screened 
Wakiso 
 
125 individuals screened 
 
0 excluded 
   0 refused consent 
   0 non-residents 
   0 unreachable 
16 excluded 
   7 refused consent 
   9 non-residents 
   0 unreachable 
10 excluded 
   8 refused consent 
   0 non-residents 
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Figure 2. Trial profile. Outlining the process of recruitment, screening and enrolment into the study. In total, 100 participants were enrolled in
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five African countries (The Gambia, Ghana, Nigeria, Uganda and
Kenya) in 2007–08, use of antibiotics to treat acute illness within
the past 2 weeks ranged from 17.6% to 42.3% in Kenya.24 Similar
results have been reported from urban settings across Africa; anti-
biotic use in the prior month was 39% among hospitalized patients
in Uganda23 and 57% amongst residents in Nigeria,38 while 49% of
residents in Ethiopia reported antibiotic use within the past year.39
Our findings of frequent antibiotic use amongst piggery and
poultry farmers in Wakiso, an area with increasing commercial
and semi-industrialized farms, also mirror rates of antibiotic use
reported elsewhere in Africa: 100% of respondents on commercial
poultry farms in Tanzania40 and Ogun State, Nigeria41 reported
frequently using antibiotics, while in Abia State, Nigeria 65% of
commercial poultry farms and 40% of piggery farms used an anti-
biotic weekly and fortnightly, respectively.42 Improvements in
technology, changes in the global economy, rapid population
growth and increased consumption of livestock products have
been reported as factors that have influenced changes globally
in farming, with many subsistence farms, with little capacity to
produce surplus for sale on the market, transitioning to com-
mercial and market-based farms, which are associated with
routine use of antimicrobials.35,43 The shift away from subsist-
ence farming towards commercial and market-based farming
could explain the rates of antibiotic use observed in commercial
farms in our study sites and in studies conducted elsewhere
in Africa.8,35
The types of antibiotics used by residents and farmers varied
widely between the three geographies. In Namuwongo, 74% of
participants reported using metronidazole frequently, compared
with only 40% of households in rural Nagongera. However, in both
sites, use of metronidazole was much higher than reports from
elsewhere in Africa.24,39 In the study conducted in five African
countries, use of metronidazole in individuals with an acute illness
who received antibiotics was 17.2% overall, ranging from 10% to
27%; in Uganda, only 11.3% received metronidazole.24 The poten-
tial impact of such high use of metronidazole, as seen in our study,
on the development of AMR requires exploration. There are
numerous potential mechanisms for metronidazole resistance to
occur,44–46 but the degree to which the high rates of metronida-
zole use have impacted (or will impact) microbial communities,
and subsequent susceptibility to therapy, remains unknown.
Overuse of metronidazole may also damage beneficial gut micro-
bial populations, which may have a negative impact on human
health and increase susceptibility to infections and disease.47,48
The high levels of metronidazole use also require exploration with
qualitative research, to understand the reasons and history of the
use of this antibiotic in our study area. Use of other antibiotics by
our study participants was more comparable across settings, and
similar to reports from elsewhere, with quite a narrow range of
‘Access’ category antibiotics available and used frequently, notably
penicillins. Further work is required to establish whether ciprofloxa-
cin and erythromycin, drugs to ‘watch’ in the WHO AWaRe system,
were prescribed, as these drugs were used less frequently in
our study sites. The range of antibiotics commonly used to treat
animals was wider in Wakiso than in Nagongera, primarily a sub-
sistence farming area, but nonetheless most antibiotics were not
Table 1. Participant characteristics
Human use Nagongera Namuwongo P value
Setting rural urban
Sample size 100 174
Gender of respondent, female 56 (56.0%) 138 (79.3%) ,0.001
Occupationa
Subsistence farmer 89 (89.0%) 7 (4.0%) ,0.001
Merchant 1 (1.0%) 103 (59.2%)
Labourer 1 (1.0%) 45 (25.9%)
Other 9 (9.0%) 19 (10.9%)
Animal use Nagongera Wakiso P value
Setting rural peri-urban
Sample size 100 115
Gender of respondent, female 56 (56.0%) 55 (47.8%) 0.23
Age (years)
,40 39 (39.0%) 41 (35.7%) 0.61
40 61 (61.0%) 74 (64.3%)
Highest level of educationb
Never went to school 16 (16.0%) 1 (0.9%) ,0.001
Primary 49 (49.0%) 23 (20.4%)
Secondary or higher 35 (35.0%) 89 (78.8%)
Occupationc
Subsistence farmer 89 (89.0%) 0 ,0.001
Farm owner 0 83 (72.2%)
Farm worker 0 32 (27.8%)
Other 11 (11.0%) 0
Farm categoriesd
Poultry
Subsistence 85 (85%) 0 ,0.001
Small (,5000 birds) 0 61 (95.3%)
Large (5000 birds) 0 3 (4.7%)
Piggery
Subsistence 38 (38%) 0 ,0.001
Small (,30 pigs) 0 47 (72.3%)
Large (30 pigs) 0 18 (27.7%)
aMerchant: engaged in selling food, drinks and other items; labourer:
making, building, fixing, cooking, cleaning; other: students (n"2), witch
doctors (n"1), drivers (n"2), boda drivers (n"1), businessmen (n"1),
rent collectors (n"1), teachers (n"4), security guards (n"8), factory
workers (n"5), masons (n"1), unemployed (n"2).
bIn Wakiso, two respondents refused to answer and were excluded
(n"113); secondary or higher: secondary-level education, certificate,
diploma, vocational training and university degree.
cFarm worker: anyone employed at the piggery or poultry farm, including
farm managers and other workers; other: teachers (n"4), students
(n"2), businessmen (n"1), masons (n"1), food sellers (n"1), un-
employed (n"2).
dIn Wakiso, poultry farms n"64, piggery farms n"65; farms defined
using the Food and Agricultural Organisation 2014 criteria. Subsistence
farms: those that produce for the farmer’s own consumption and with
little or no capacity to generate surplus production for the market; small
farms: those that are either market-oriented and commercial, generat-
ing surplus production for a market (local, national or international), or
have the potential to become market-oriented; large farms: those show-
ing characteristics of industrial ventures.
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‘critically important’, except for dihydrostreptomycin sulphate,
erythromycin sulphate and tylosin tartrate. Notably, a few partici-
pants in Wakiso reported using colistin frequently. The most
commonly used antibiotic in both sites was oxytetracycline hydro-
chloride, consistent with findings reported from studies conducted
between 1998 and 2018 on commercial farms from Tanzania,40
Ghana49 and Nigeria50 and a wider review of veterinary use of anti-
microbials in LMICs.51
Antibiotics were mainly acquired through the private sector
for both human and animal use in all three study areas. This is con-
sistent with results of prior studies of antibiotic access for humans
in Uganda,52 Ethiopia39 and Tanzania,53 for commercial poultry
production in Nigeria41 and Ghana,49 and studies of antibiotic
access for animals in Rwanda.54 Understanding the forces that
draw people to the private sector is important, including how the
pharmaceutical industry operates and is regulated. The favourable
Table 2. Antibiotic use and the source of medicines for treatment of humans
Human use Nagongera (n"100) Namuwongo (n"174) PR (95% CI) P value
Ever use antibioticsa
Yes 95 (95.0%) 170 (97.7%) 0.97 (0.92–1.02) 0.29
No 5 (5.0%) 4 (2.3%)
Frequency of antibiotic useb
1 month 71 (74.7%) 117 (68.8%) 1.09 (0.93–1.27) 0.33
.1 month 24 (25.3%) 53 (31.2%) 0.81 (0.54–1.22) 0.33
Source of medicines
Public health facilities 80 (84.2%) 39 (22.9%) 3.67 (2.75–4.90) ,0.001
Research/non-governmental organizations 1 (1.1%) 8 (4.7%) 0.22 (0.03–1.76) 0.16
Otherc 83 (87.4%) 129 (75.9%) 1.15 (1.03–1.29) 0.03
aAntibiotic use was defined as taking any antibiotic for any indication at whatever dosage as reported by participants.
bIn Nagongera, participants reported how often any antibiotic was used to treat any member of the household for any indication and in any dosage;
in Namuwongo, participants reported the last time any antibiotic was used for any indication and in any dosage, with or without a prescription.
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cefixime amoxicillin/clavulanic acid cefalexin (cephalexin)
azithromycin/secnidazole/fluconazole ceftriaxone benzylpenicillin
ofloxacin
Figure 3. Antibiotics used frequently for human treatment, as reported by participants. Antibiotics were identified by participants using the drug bag
method and are presented as the percentage of participants who reported using the antibiotic frequently to treat members of their household.
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tax environment in Uganda, where no taxes are levied on imported
pharmaceuticals for either humans or animals,55 and a growing
pharmaceutical market valued at US$276 million in 201056 and
$414 million in 2017,57 enable the pharmaceutical industry to
flourish while being dominated by imported pharmaceuticals.
With the deterioration of the public health system for both
humans and animals over many years,58,59 it has been estimated
that 60%–70% of human healthcare services and all veterinary
clinical services in Uganda are provided by the private sector.58–60
These factors enable the existence of a dominant private sector in
Uganda today.
Our study had several important limitations. First, our findings
are based on self-reported use of antibiotics, which may not reflect
the full picture of antibiotic use for human and animal health.
However, we do expect our findings to be a more accurate repre-
sentation of self-reporting due to the use of physical samples with
the drug bag method in both homes and farms in order to avoid
linguistic and classification errors in antibiotic knowledge.30
Second, we relied on convenience sampling to recruit participants
into the surveys. Thus, the findings from these surveys are not gen-
eralizable to the wider Ugandan population, but they do provide
insights into antibiotic-use experiences from three different con-
texts, underscoring the uniqueness of each setting. Third, we relied
on a self-determined classification of ‘frequently used’ for antibiot-
ics, which could vary between individuals. This was in recognition
of inaccuracies in reporting health events for time periods over
about 2 weeks61 and reflected our interest in whether these medi-
cines were often used, rather than just in a recent time period.




(AWaRe)a Nagongera Namuwongo PR (95% CI) P value
Penicillin amoxicillin Access 58 (58.0%) 58 (33.3%) 1.74 (1.33–2.28) ,0.001
ampicillin Access 10 (10.0%) 1 (0.6%) 17.4 (2.26–133.93) ,0.001
phenoxymethylpenicillin Access 3 (3.0%) 14 (8.1%) 0.37 (0.11–1.27) 0.12
ampicillin/cloxacillin Access 14 (14.0%) 79 (45.4%) 0.31 (0.18–0.51) ,0.001
Cephalosporin cefalexin Access 1 (1.0%) 4 (2.3%) 0.44 (0.05–3.84) 0.66
Metronidazole metronidazole Access 40 (40.0%) 128 (73.6%) 0.54 (0.42–0.70) ,0.001
Sulphonamide trimethoprim/
sulfamethoxazole
Access 42 (42.0%) 50 (28.7%) 1.46 (1.05–2.03) 0.03
Fluoroquinolone ciprofloxacin Watch 9 (9.0%) 29 (16.7%) 0.54 (0.27–1.09) 0.10
Chloramphenicol chloramphenicol Access 6 (6.0%) 11 (6.3%) 0.95 (0.36–2.49) 1.00
Macrolide erythromycin Watch 9 (9.0%) 32 (18.4%) 0.49 (0.24–0.98) 0.04
Tetracycline tetracycline Access 4 (4.0%) 9 (5.2%) 0.77 (0.24–2.45) 0.77
doxycycline Access 15 (15.0%) 31 (17.8%) 0.84 (0.48–1.48) 0.62
aThe WHO’s AWaRe classification aims at informing effective antimicrobial stewardship and ensuring access to necessary antibiotics and appropriate
prescribing; categories include ‘Access’, ‘Watch’ and ‘Reserve’. Access: first- and second-choice antibiotics for common infections that should be wide-
ly available, affordable and quality assured; Watch: first- and second-choice antibiotics recommended for specific and limited number of indications
because they have a higher potential for development of resistance.
Table 4. Antibiotic use and the source of medicines for treatment of animals
Animal use Nagongera (n"100) Wakiso (n"115) PR (95% CI) P value
Ever use antibioticsa
Yes 33 (33.0%) 99 (86.1%) 0.33 (0.25–0.44) ,0.001
No 67 (67.0%) 1 (0.9%)
Frequency of antibiotic useb
1 month 15 (45.5%) 82 (82.8%) 0.55 (0.37–0.81) ,0.001
.1 month 18 (54.5%) 17 (17.2%) 3.18 (1.86–5.41) ,0.001
Source of medicines
Veterinary pharmacy/drug shop 30 (90.9%) 77 (77.8%) 1.17 (1.01–1.36) 0.13
Veterinary officer 0 23 (23.2%) 0 0.001
Market 3 (9.1%) 0 0.01
aAntibiotic use was defined by participants as using any antibiotic for treatment of animals for any indication at any dose; in Wakiso, 15 respondents
didn’t know if antibiotics had been used to treat their animals (n"115).
bIn Nagongera, participants reported how often any antibiotic was used to treat animals kept by the household for any indication and in any dosage;
in Wakiso, participants reported the last time any antibiotic was used on the farm for any indication and in any dosage.
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Finally, very few large-scale farms were included, which may cre-
ate a gap for further research to fully understand antibiotic-use
experiences in such spaces.
The implications of these findings for policy lie in the need to
recognize the increasing reliance on many of these medicines and
the important role of the private sector in providing access to
antibiotics.
Interventions aimed at changing the knowledge and behaviour
of healthcare professionals and the general public through educa-
tion on the importance of using antimicrobials appropriately, and
the dangers that may arise from the misuse of antimicrobials,
have had limited impact in some areas.20 Lessons can be learned
from the challenges faced in attempting to reduce antibiotic use
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Figure 4. Antibiotics used frequently for animal treatment, as reported by participants. Antibiotics were identified by participants using the drug bag
method and are presented as the percentage of participants who reported using the antibiotic frequently to treat animals of their household. In total,
20 antibiotics in Wakiso and 7 in Nagongera were identified.
Table 5. Antibiotics used frequently for treatment of animals
Antibiotic classes
for animal use Antibiotic
WHO classification
(CIA)a Nagongera Wakiso PR (95% CI) P value
Penicillin/aminoglycoside procaine penicillin/ highly important 3 (3.0%) 24 (20.9%) 0.14 (0.04–0.46) ,0.001
dihydrostreptomycin
sulphate
critically important 3 (3.0%) 24 (20.9%) 0.14 (0.04–0.46) ,0.001
Sulphonamide trimethoprim/sulfadiazine highly important 1 (1.0%) 39 (33.9%) 0.03 (0.004–0.21) ,0.001
Macrolide erythromycin sulphate critically important 2 (2.0%) 9 (7.8%) 0.26 (0.06–1.16) 0.07
tylosin tartrate critically important 0 23 (20.0%) 0 ,0.001
Tetracycline oxytetracycline
hydrochloride
highly important 31 (31.0%) 88 (76.5%) 0.41 (0.30–0.55) ,0.001
aThe WHO’s CIA classification aims at ensuring that antimicrobials, particularly those classified as critically important, are used with caution both in
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Rather, an in-depth understanding of the relationships between
people, animals and medicines could provide alternative paths to
intervention. Further research is required to understand why we
found such heterogeneity between local geographies in the fre-
quency and types of antibiotics used, and why particular antibiotics
were so commonly used. Such research should trace the histories
and current everyday realities of particular antibiotics across differ-
ent settings to help clarify why and how antibiotics are used in dif-
ferent settings. It is also essential to harmonize these results with
medical microbiological data to understand the impacts that
short- and longer-term trends of antibiotic use may have on micro-
bial populations and drug-resistant infections. Finally, our findings
demonstrate the ongoing importance of addressing the roles of
antimicrobial markets beyond the formal health sector when
developing programmes to optimize antibiotic use.
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